Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Dhruva Dave
Institutions:
University of Alabama at Birmingham,
UAB Medicine,
O'Neal Comprehensive Cancer Center
Observed institutions:
University of Alabama at Birmingham,
UAB Medicine,
O'Neal Comprehensive Cancer Center
ORCID:
0000-0002-8334-2158
Observed ORCID:
0000-0002-8334-2158
OpenAlex ID:
A5122833699
Global, regional and national burden of cervical cancer in 1990–2023 with forecasts to 2050: a Global Burden of Disease study
2026
·
Natalie Pritchett
, Miranda L. May
, et al.
·
Nature Medicine
·
15
PDF
Translational science in modern gynecologic oncology trials
2026
·
Rebecca C. Arend
, Dhruva Dave
, et al.
·
Gynecologic Oncology
Evaluation of xenograft alignment with patient tumors to inform treatment studies in uterine carcinosarcoma.
2026
·
Dhruva Dave
, Rebecca Christian Arend
, et al.
·
Journal of Clinical Oncology
Survival differences in advanced gynecological cancers after the development of immune checkpoint inhibitors and targeted therapy: United States SEER-based population study.
2026
·
Binay Kshetree
, Dhruva Dave
, et al.
·
Journal of Clinical Oncology
Comorbidities among women with gynecologic cancers or benign gynecologic conditions at hysterectomy or bilateral salpingo-oophorectomy
2026
·
Akemi Wijayabahu
, Rebecca Arend
, et al.
·
Gynecologic Oncology
Evaluating race, urbanicity, and distance to care as predictors of clinical trial enrollment in patients with advanced-stage ovarian cancer
2026
·
Kati Turner
, Paxton Gillispie
, et al.
·
Gynecologic Oncology
Age-specific incidence and survival of uterine sarcoma by histotype, race, and ethnicity in the United States, 2000–2019
2026
·
Dhruva Dave
, Rebecca Arend
, et al.
·
Gynecologic Oncology
The discovery and evaluation of testing for uterine cancer in tampons (DETECT) study: Rationale and baseline findings
2026
·
Nicolas Wentzensen
, Akemi Wijayabahu
, et al.
·
Gynecologic Oncology
Evaluating the CA-125 KELIM™ score across racial groups as a predictor of chemotherapy response and survival in advanced epithelial ovarian cancer
2026
·
Kati Turner
, Isabella Baker
, et al.
·
Gynecologic Oncology
Decoding HRD: A Genomic LOH-Based Assay Associated With Platinum Response and Survival in High-Grade Serous Ovarian Cancer
2026
·
Yi-Hsuan Lucy Lai
, Peining Yu
, et al.
·
Research Square
PDF
Abstract 2616: ECM profiling of patient-matched endometrial PDX-tumors reveals translational drift and TME remodeling.
2026
·
Dhruva Dave
, Rebecca Christian Arend
, et al.
·
Cancer Research
Oxidative DNA damage as a predictive biomarker for recurrence and survival in high-grade serous ovarian cancer
2026
·
Carson Edwards
, Dhruva Dave
, et al.
·
Gynecologic Oncology
Patient-Derived Microtumors: How Can We Continue to Personalize Treatment for Ovarian Cancer Patients?
2026
·
Emily O'Brien
, Dhruva Dave
, et al.
·
Targets
PDF
Show more works
View as search
Works count:
13
Citation count:
15
H-index:
1
I10-index:
1
Year
Topic
Type